Phorbol-ester-stimulated human lymphoid cell lines produce a plasminogen activator modulator inducing cell-bound urokinase-type plasminogen activator in malignant tumor cell lines

International Journal of Cancer

Volumn 65, Issue 2, 1996, Pages 178-185

  Osada, Hiroshi ^a,c   Kono, Toshiaki ^c   Miwa, Kyoko ^b,c   Yamada, Chikako ^c  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b FUJIREBIO INC   (Japan)

^c SAGAMI CHEMICAL RESEARCH CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; PHORBOL ESTER; PLASMINOGEN ACTIVATOR; SARUPLASE; UROKINASE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOID CELL LINE; PRIORITY JOURNAL; TUMOR CELL LINE;

CELL LINE; CULTURE MEDIA, CONDITIONED; DACTINOMYCIN; HUMANS; LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED; UP-REGULATION; URINARY PLASMINOGEN ACTIVATOR;

EID: 0030029966     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960117)65:2<178::AID-IJC9>3.0.CO;2-W     Document Type: Article

References (28)

1. ALTIOK, A., EHLIN-HENRIKSSON, B and KLEIN, E., Correlation between the growth-inhibitory effect of TGF-β1 and phenotypic characteristics in a panel of B-cell lines. Int. J. Cancer, 55, 137-140 (1993).
2. BLASI, F., Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. BioEssays, 15, 105-111 (1993).
3. BRUNNER, G., SIMON, M.M. and KRAMER, M.D., Activation of prourokinase by the human T-cell-associated serine proteinase HuTSP-1. FEBS Lett., 260, 141-144 (1990).
4. CALMAN, A.F. and PETERLIN, B.M., Mutant human B cell lines deficient in class-II major histocompatibility complex transcription. J. Immunol., 139, 2489-2495 (1987).
5. DANØ, K., ANDREASEN, P.A., GRØNDAHL-HANSEN, J., KRISTENSEN, P., NIELSEN, L.S. and SKRIVER, L., Plasminogen activators, tissue degradation and cancer. Advanc. Cancer Res., 44, 139-266 (1985).
6. DAO, T., HOLÁN̄, V. and MINOWADA, J., Multiple and heterogeneous patterns of cytokine production in 18 leukemia and in vitro-transformed mature T-cell lines reflect the individuality of human leukemias. Int. J. Haematol., 57, 139-146 (1993).
7. EGUCHI, Y., SAKATA, Y., MATSUDA, M., OSADA, H., NUMAO, N., OHMORI, M. and KONDO, K., Characterization of thrombin- and plasmin-resistant mutants of recombinant human single chain urokinase-type plasminogen activator. J. Biochem., 108, 72-79 (1990).
8. ELLIS, V., PYKE, C., ERIKSEN, J , SOLBERG, H. and DANØ, K., The urokinase receptor: involvement in cell surface proteolvsis and cancer invasion. Ann. N. Y. Acad. Sci., 667, 13-31 (1992).
9. FINGER, L.R., HUEBNER, K., CANNIZZARO, L.A., MCLEOD, K., NOWELL, P.C. and CROCE, C.M., Chromosomal translocation in T-cell leukemia line HUT 78 results in a MYC fusion transcript. Proc nat. Acad. Sci. (Wash.), 85, 9158-9162 (1988).
10. FINKE, J., FRITZEN, R., TERNES, P., TRIVEDI, P., BROSS, K.J., LANGE, W., MERTELSMANN, R. and DÖLKEN, G., Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Blood, 80, 459-469 (1992).
11. KATAOKA, H., DECASTRO, R., ZUCKER, S. and BISWAS, C., Tumor-cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin and 72-kDa gelatinase. Cancer Res., 53, 3154-3158 (1993).
12. LAIHO, M. and KESKI-OJA, J., Growth factors in the regulation of pericellular proteolysis: a review. Cancer Res., 49, 2533-2553 (1989).
13. LUND, L.R., RØMER, J., RØNNE, E., ELLIS, V., BLASI, F. and DANØ, K., Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor β1 in human A549 lung carcinoma cells. EMBO J., 10, 3399-3407 (1991).
14. MANTOVANI, A., BOTTAZZI, B., COLOTTA, F., SOZZANI, S. and RUCO, L., The origin and function of tumor-associated macrophages. Immunol. Today, 13, 265-270 (1992).
15. MINOWADA, J., Leukemia cell lines. Cancer Rev., 10, 1-18 (1988).
16. MIWA, K., YAMADA, C., KONO, T. and OSADA, H., Retinoic acid enhances plasminogen activation on the cell surface. Thromb. Res, 80, 47-56 (1995).
17. NAKAJIMA, M. and CHOP, A.M., Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors. Semin. Cancer Biol., 2, 115-127 (1991).
18. NYKJÆR, A., MØLLER, B , TODD, R.F., III, CHRISTENSEN, T., ANDREASEN, P.A., GLIEMANN, J. and PETERSEN, C.M., Urokinase receptor. An activation antigen in human T lymphocytes. J. Immunol., 152, 505-516 (1994).
19. OSADA, H., YAMADA, C., MIWA, K., KONO, T. and OH-HIRA, M., An assay system for the modulators of plasminogen activation on the cell surface. Thromb. Res, 62, 519-530 (1991).
20. PEPPER, M.S., MATSUMOTO, K., NAKAMURA, T., ORCI, L. and MONTESANO, R., Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells. J. biol. Chem., 267, 20493-20496 (1992).
21. PYKE, C., GRÆM, N., PALFKIÆR, E., RØNNE, G., HØYER-HANSEN, N., BRÜNNER, N. and DANØ, K., Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res., 53, 1911-1915 (1993).
22. PYKE, C., KRISTENSEN, P., PALFKIÆR, E., GRØNDAHL-HANSEN, J., ERIKSEN, J., BLASI, F. and DANØ, K., Urokinase-type plasminogen activator is expressed in stroma cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Amer. J. Pathol., 138, 1059-1067 (1991).
23. RABBITTS, T.H., FORSTER, A., HAMLYN, P. and BAER, R., Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma. Nature (Lond.), 309, 592-597 (1984).
24. SAKSELA, O. and RIFKIN, D.B., Cell-associated plasminogen activation: regulation and physiological functions. Ann. Rev. Cell Biol., 4, 93-126 (1988).
25. STEWART, T.H.M. and TSAI, S.-C.J., The possible role of stromal cell stimulation in worsening the prognosis of a subset of patients with breast cancer. Clin. exp. Metast., 11, 295-305 (1993).
26. VENUAT, A.-M., SORIA, C., SORIA, J., KRIEF, P., MIRSHAHI, M., HE, L., THOMAIDIS, A., HOULLIER, A., BILLARD, M. and BOUCHEIX, C., High frequency of plasminogen activator secretion by malignant human lymphoid cell lines of T-cell type origin. Cancer, 62, 1952-1957 (1988).
27. WHITESIDE, T.L., JOST, L.M. and HERBERMAN, R.B., Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy. Crit. Rev. Oncol./Hematol., 12, 25-47 (1992).
28. WOLF, C., ROUYER, N., LUTS, Y., ADIDA, C., LORIOT, M., BELLOCQ, J.-P., CHAMBON, P. and BASSET, P., Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc. nat. Acad. Sci. (Wash.), 90, 1843-1847 (1993).